OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/12/2026
Back to search
Official data from USPTO
HEPFAXI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
08/12/2026
Trademark type
Word
Nice classes
5
Filing date
01/17/2025
Registration date
11/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/04/2025
Last transaction
08/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
77
Owner location
Dublin, IE
Examiner
BARRETT, LEAH N
Law office
L60
Current location
TMEG LAW OFFICE 106
Holders and representatives
Holders
Bausch Health Ireland Limited
Representatives
Jeremy Blackowicz Bausch Health Companies
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of autoimmune conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of blood conditionsdiseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of conditionsdiseasesdisorders of the central and peripheral nervous system; pharmaceutical preparations for the prevention and treatment of dermatological conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of endocrine conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of gastrointestinal conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of hepatic conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of immunological conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of infectious diseases; pharmaceutical preparations for the prevention and treatment of inflammatory conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of metabolic conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of muscular conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of neurological conditionsdiseasesdisorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the prevention and treatment of psychiatric conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of respiratory and pulmonary conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of renal conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of urological conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of viral diseases.
Publications
History of USPTO decisions and trademark events.
29 publications found
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/12/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/11/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/22/2026
FIMP
FINAL DISPOSITION PROCESSED
05/22/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/04/2026
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
12/18/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
11/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/16/2025
PUBO
PUBLISHED FOR OPPOSITION
09/16/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/10/2025
RFNT
REFUSAL PROCESSED BY IB
08/29/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/19/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
08/19/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/19/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
08/19/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/19/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/18/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/18/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/18/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/14/2025
RFRR
REFUSAL PROCESSED BY MPU
08/13/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/02/2025
CNRT
NON-FINAL ACTION WRITTEN
07/01/2025
DOCK
ASSIGNED TO EXAMINER
06/26/2025
MAFR
APPLICATION FILING RECEIPT MAILED
03/16/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/16/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/13/2025
Continuous trademark protection
Get notified about every new filing that threatens HEPFAXI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.